litlas
ログインアカウント作成

Bo Xiang

2008–2027 年に発表

203
論文数
18,770
被引用数
77
h 指数
171
i10 指数

被引用数

Bo Xiang の年別被引用数2006 年: 被引用 1 件2009 年: 被引用 2 件2010 年: 被引用 9 件2011 年: 被引用 20 件2012 年: 被引用 35 件2013 年: 被引用 33 件2014 年: 被引用 32 件2015 年: 被引用 46 件2016 年: 被引用 58 件2017 年: 被引用 121 件2018 年: 被引用 198 件2019 年: 被引用 660 件2020 年: 被引用 823 件2021 年: 被引用 1,006 件2022 年: 被引用 894 件2023 年: 被引用 785 件2024 年: 被引用 1,289 件2025 年: 被引用 839 件2026 年: 被引用 27 件2027 年: 被引用 1 件2007〜2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 3,198 件、この内訳の 42.8%アメリカ合衆国: 引用元論文 996 件、この内訳の 13.3%インド: 引用元論文 218 件、この内訳の 2.9%ドイツ: 引用元論文 211 件、この内訳の 2.8%イタリア: 引用元論文 207 件、この内訳の 2.8%イギリス: 引用元論文 198 件、この内訳の 2.6%カナダ: 引用元論文 163 件、この内訳の 2.2%イラン: 引用元論文 163 件、この内訳の 2.2%韓国: 引用元論文 161 件、この内訳の 2.2%サウジアラビア: 引用元論文 160 件、この内訳の 2.1%オーストラリア: 引用元論文 111 件、この内訳の 1.5%フランス: 引用元論文 107 件、この内訳の 1.4%
0%42.8%その他 21.2%

機関

分野

  • Biochemistry, Genetics and Molecular Biology44.5%
  • Medicine35.9%
  • Immunology and Microbiology5.9%
  • Engineering4.1%
  • Computer Science2.7%
  • Neuroscience1.7%
  • その他5.2%

トピック

  • Cancer-related molecular mechanisms research6%
  • Cancer Immunotherapy and Biomarkers4%
  • Circular RNAs in diseases3.8%
  • RNA modifications and cancer3.7%
  • MicroRNA in disease regulation3.4%
  • Ferroptosis and cancer prognosis2.4%
  • その他76.7%

共著者

全論文

検索で開く
  1. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape

    著者: Xianjie Jiang, Jie Wang, Xiangying Deng, Fang Xiong, Junshang Ge, Bo Xiang, Xu Wu, Jian Ma, Ming Zhou, Xiaoling Li, Yong Li, Guiyuan Li, Wei Xiong, Can Guo, Zhaoyang Zeng - Molecular Cancer 2019 被引用: 1,479

  2. The role of microenvironment in tumor angiogenesis

    著者: Xianjie Jiang, Jie Wang, Xiangying Deng, Fang Xiong, Shanshan Zhang, Zhaojian Gong, Xiayu Li, Ke Cao, Hao Deng, Yi He, Qianjin Liao, Bo Xiang, Ming Zhou, Can Guo, Zhaoyang Zeng, Guiyuan Li, Xiaoling Li, Wei Xiong - Journal of Experimental & Clinical Cancer Research 2020 被引用: 761

  3. Regulatory mechanisms of PD-1/PD-L1 in cancers

    著者: Xin Lin, Kuan Kang, Pan Chen, Zhaoyang Zeng, Guiyuan Li, Wei Xiong, Mei Yi, Bo Xiang - Molecular Cancer 2024 被引用: 635

  4. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments

    著者: Xiaoxu Wei, Yunhua Chen, Xianjie Jiang, Peng Miao, Yiduo Liu, Yongzhen Mo, Daixi Ren, Yuze Hua, Boyao Yu, Yujuan Zhou, Qianjin Liao, Hui Wang, Bo Xiang, Ming Zhou, Xiaoling Li, Guiyuan Li, Yong Li, Wei Xiong, Zhaoyang Zeng - Molecular Cancer 2021 被引用: 474

  5. Pyroptosis: a new paradigm of cell death for fighting against cancer

    著者: Yixin Tan, Quanzhu Chen, Xiaoling Li, Zhaoyang Zeng, Wei Xiong, Guiyuan Li, Xiayu Li, Jianbo Yang, Bo Xiang, Mei Yi - Journal of Experimental & Clinical Cancer Research 2021 被引用: 485

  6. Chronic Stress Promotes Cancer Development

    著者: Shirui Dai, Yongzhen Mo, Yumin Wang, Bo Xiang, Qianjin Liao, Ming Zhou, Xiaoling Li, Yong Li, Wei Xiong, Guiyuan Li, Can Guo, Zhaoyang Zeng - Frontiers in Oncology 2020 被引用: 402

  7. Pyroptosis in health and disease: mechanisms, regulation and clinical perspective

    著者: Yifan Liu, Renjie Pan, Yuzhen Ouyang, Wangning Gu, Tengfei Xiao, Hongmin Yang, Ling Tang, Hui Wang, Bo Xiang, Pan Chen - Signal Transduction and Targeted Therapy 2024 被引用: 261

  8. Discovering topics and trends in the field of Artificial Intelligence: Using LDA topic modeling

    著者: Dejian Yu, Bo Xiang - Expert Systems with Applications, Expert Syst. Appl. 2023 被引用: 158

  9. Regulatory pathways and drugs associated with ferroptosis in tumors

    著者: Dan Wang, Le Tang, Yijie Zhang, Guili Ge, Xianjie Jiang, Yongzhen Mo, Pan Wu, Xiangying Deng, Lvyuan Li, Sicheng Zuo, Qijia Yan, Shanshan Zhang, Fuyan Wang, Lei Shi, Xiayu Li, Bo Xiang, Ming Zhou, Qianjin Liao, Can Guo, Zhaoyang Zeng, Wei Xiong, Zhaojian Gong - Cell Death and Disease 2022 被引用: 123

  10. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1

    著者: Jie Wang, Junshang Ge, Yian Wang, Fang Xiong, Jiayue Guo, Xianjie Jiang, Lishen Zhang, Xiangying Deng, Zhaojian Gong, Shanshan Zhang, Qijia Yan, Yi He, Xiayu Li, Lei Shi, Can Guo, Fuyan Wang, Zheng Li, Ming Zhou, Bo Xiang, Yong Li, Wei Xiong, Zhaoyang Zeng - Nature Communications 2022 被引用: 192

  11. RNA modifications in cancer

    著者: Qiling Tang, Lvyuan Li, Yumin Wang, Pan Wu, Xiangchan Hou, Jiawei Ouyang, Chunmei Fan, Zheng Li, Fuyan Wang, Can Guo, Ming Zhou, Qianjin Liao, Hui Wang, Bo Xiang, Weihong Jiang, Guiyuan Li, Zhaoyang Zeng, Wei Xiong - British Journal of Cancer 2023 被引用: 135

  12. Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ

    著者: Jing Cai, Mei Yi, Yixin Tan, Xiaoling Li, Guiyuan Li, Zhaoyang Zeng, Wei Xiong, Bo Xiang - Journal of Experimental & Clinical Cancer Research 2021 被引用: 208

  13. Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy

    著者: Daixi Ren, Yuze Hua, Boyao Yu, Xin Ye, Ziheng He, Chunwei Li, Jie Wang, Yongzhen Mo, Xiaoxu Wei, Yunhua Chen, Yujuan Zhou, Qianjin Liao, Hui Wang, Bo Xiang, Ming Zhou, Xiaoling Li, Guiyuan Li, Yong Li, Zhaoyang Zeng, Wei Xiong - Molecular Cancer 2020 被引用: 331

  14. Epstein–Barr Virus–Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1

    著者: Junshang Ge, Jie Wang, Fang Xiong, Xianjie Jiang, Kunjie Zhu, Yian Wang, Yongzhen Mo, Zhaojian Gong, Shanshan Zhang, Yi He, Xiayu Li, Lei Shi, Can Guo, Fuyan Wang, Ming Zhou, Bo Xiang, Yong Li, Guiyuan Li, Wei Xiong, Zhaoyang Zeng - Cancer Research 2021 被引用: 219

  15. Role of metabolism in cancer cell radioresistance and radiosensitization methods

    著者: Le Tang, Fang Wei, Yingfen Wu, Yi He, Lei Shi, Fang Xiong, Zhaojian Gong, Can Guo, Xiayu Li, Hao Deng, Ke Cao, Ming Zhou, Bo Xiang, Xiaoling Li, Yong Li, Guiyuan Li, Wei Xiong, Zhaoyang Zeng - Journal of Experimental & Clinical Cancer Research 2018 被引用: 420

  16. Emerging role of lipid metabolism alterations in Cancer stem cells

    著者: Mei Yi, Junjun Li, Shengnan Chen, Jing Cai, Yuanyuan Ban, Qian Peng, Ying Zhou, Zhaoyang Zeng, Shuping Peng, Xiaoling Li, Wei Xiong, Guiyuan Li, Bo Xiang - Journal of Experimental & Clinical Cancer Research 2018 被引用: 262

  17. Long non-coding RNAs are involved in alternative splicing and promote cancer progression

    著者: Jiawei Ouyang, Yu Zhong, Yijie Zhang, Liting Yang, Pan Wu, Xiangchan Hou, Fang Xiong, Xiayu Li, Shanshan Zhang, Zhaojian Gong, Yi He, Yanyan Tang, Wenling Zhang, Bo Xiang, Ming Zhou, Jian Ma, Yong Li, Guiyuan Li, Zhaoyang Zeng, Can Guo, Wei Xiong - British Journal of Cancer 2021 被引用: 149

  18. Correction to: Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ

    著者: Jing Cai, Mei Yi, Yixin Tan, Xiaoling Li, Guiyuan Li, Zhaoyang Zeng, Wei Xiong, Bo Xiang - Journal of Experimental & Clinical Cancer Research 2021 被引用: 84

  19. Circular RNAs in human cancer

    著者: Yumin Wang, Yongzhen Mo, Zhaojian Gong, Xiang Yang, Mo Yang, Shanshan Zhang, Fang Xiong, Bo Xiang, Ming Zhou, Qianjin Liao, Wenling Zhang, Xiayu Li, Xiaoling Li, Yong Li, Guiyuan Li, Zhaoyang Zeng, Wei Xiong - Molecular Cancer 2017 被引用: 528

  20. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer

    著者: Mei Yi, Yuanyuan Ban, Yixin Tan, Wei Xiong, Guiyuan Li, Bo Xiang - Molecular Metabolism 2018 被引用: 193

  21. Effects of tumor metabolic microenvironment on regulatory T cells

    著者: Yian Wang, Xiaoling Li, Yongzhen Mo, Chunmei Fan, Le Tang, Fang Xiong, Can Guo, Bo Xiang, Ming Zhou, Jian Ma, Xi Huang, Xu Wu, Yong Li, Guiyuan Li, Zhaoyang Zeng, Wei Xiong - Molecular Cancer 2018 被引用: 185

  22. Mitochondrial Sirtuin-3 (SIRT3) Prevents Doxorubicin-Induced Dilated Cardiomyopathy by Modulating Protein Acetylation and Oxidative Stress

    著者: Mateusz M. Tomczyk, Kyle G. Cheung, Bo Xiang, Nahid Tamanna, Ana L. Fonseca Teixeira, Prasoon Agarwal, Stephanie M. Kereliuk, Victor Spicer, Ligen Lin, Jason Treberg, Qiang Tong, Vernon W. Dolinsky - Circulation Heart Failure 2022 被引用: 80

  23. Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas

    著者: Yi Ji, Siyuan Chen, Kaiying Yang, Xuepeng Zhang, Jiangyuan Zhou, Lizhi Li, Bo Xiang, Tong Qiu, Shiyi Dai, Xian Jiang, Guoyan Lu, Liqing Qiu, Feiteng Kong, Yongbo Zhang - JAMA Otolaryngology–Head & Neck Surgery 2021 被引用: 84

  24. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy

    著者: Chunmei Fan, Shanshan Zhang, Zhaojian Gong, Xiayu Li, Bo Xiang, Hao Deng, Ming Zhou, Guiyuan Li, Yong Li, Wei Xiong, Zhaoyang Zeng, Xiaoling Li - Science China Life Sciences 2020 被引用: 82